What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 6 minute read Pharma Industry News Shuttle to enter $3.24bn AI pharmaceutical market via acquisition of Molecule.ai Find out how Shuttle Pharmaceuticals’ $10 million acquisition of Molecule.ai could reshape its R&D strategy and redefine the $3.24 billion AI pharma landscape. bySoujanya RaviOctober 10, 2025